Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2022-02-01 00:00:00 ET · period of report 2022-01-28 · accession 0001209191-22-005923 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-01 | 2022-01-28 | ALXO | Pinto Shelly | VP, CAO, Fin | A - Grant | $0.00 | +50.0K | 50.4K | +11,211% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-28 | A | A | 50,000 | $0.00 | 50,446 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest as follows: three-eighths of the RSUs vest on July 3, 2023 and the remaining RSUs vest thereafter in five equal semiannual installments. (F2) Includes 446 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021. |